Development agreements require legal possession or effective enjoyment for capital gains transfer; permissive possession and deferred consideration de...
Prolonged sterilisation of development rights supports capital-gains treatment, while business-income disallowances cannot govern capital-gains comput...
Additional evidence in transfer pricing dispute leads to fresh examination, while tax deductions, TDS credit, fee and refund interest require verifica...
Category II AIF pass-through taxation preserves non-business income character; investment receipts cannot be reclassified without applying recognised ...
The AAR held that the three diagnostic test kits are properly classifiable under HSN 3002 rather than HSN 3822, applying the principle affirmed by the SC in analogous precedent. Consequently, the applicant's goods do not fall within the residual chemical preparations heading and are taxable as instruments/reagents for diagnostic purposes. The applicant is directed to discharge GST at the concessional rate of 5% under Schedule I, Sr. No. 180. The ruling determines classification and tax liability prospectively for the applicant, subject to statutory compliance and any rights of appeal available under the governing indirect tax jurisprudence.
The AAR held that the three diagnostic test kits are properly classifiable under HSN 3002 rather than HSN 3822, applying the principle affirmed by the SC in analogous precedent. Consequently, the applicant's goods do not fall within the residual chemical preparations heading and are taxable as instruments/reagents for diagnostic purposes. The applicant is directed to discharge GST at the concessional rate of 5% under Schedule I, Sr. No. 180. The ruling determines classification and tax liability prospectively for the applicant, subject to statutory compliance and any rights of appeal available under the governing indirect tax jurisprudence.
Note: It is a system-generated summary and is for quick reference only.